US Stock MarketDetailed Quotes

EGRX Eagle Pharmaceuticals

Watchlist
  • 5.720
  • -0.020-0.35%
Close Jul 26 16:00 ET
  • 5.630
  • -0.090-1.57%
Pre 07:55 ET
74.12MMarket Cap6.50P/E (TTM)

Eagle Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-100.29%-126K
-101.75%-33.51M
79.67%50.7M
364.76%37.56M
-1,340.58%-13.24M
400.31%42.99M
-258.53%-16.61M
-42.99%28.22M
-59.10%8.08M
-81.04%1.07M
Net income from continuing operations
154.65%5.16M
-86.95%5.75M
513.14%35.64M
231.78%8.17M
-26.84%-7.13M
-361.63%-9.45M
10,565.08%44.06M
-171.96%-8.63M
-176.90%-6.2M
-179.64%-5.62M
Operating gains losses
-106.54%-210K
-83.04%326K
79.85%9.86M
-264.32%-6.06M
352.68%10.79M
-35.97%3.21M
134.32%1.92M
3.47%5.48M
174.52%3.69M
-60.59%2.38M
Depreciation and amortization
241.49%5.58M
512.33%5.56M
219.79%12.02M
427.65%5.63M
326.58%3.85M
82.77%1.63M
1.34%908K
6.27%3.76M
20.84%1.07M
4.76%903K
Deferred tax
11.38%-1.78M
10.24%-2.18M
-130.07%-8.32M
-230.05%-3.58M
91.84%-298K
-1,027.65%-2.01M
-369.62%-2.43M
-139.44%-3.62M
-778.13%-1.09M
-383.71%-3.65M
Other non cash items
190.27%1.16M
11.78%446K
-31.91%1.45M
-83.94%178K
103.02%471K
26.10%401K
-15.11%399K
-53.83%2.13M
-66.71%1.11M
-63.00%232K
Change In working capital
-131.83%-14.23M
26.93%-48.05M
-272.00%-16.4M
504.24%29.11M
-993.35%-24.46M
878.80%44.71M
-951.50%-65.76M
1,068.75%9.54M
-19.18%4.82M
121.16%2.74M
-Change in receivables
-100.41%-186K
52.61%-42.52M
-423.56%-30.83M
485.12%24.49M
-250.37%-11.01M
682.70%45.4M
-1,644.06%-89.71M
406.10%9.53M
286.88%4.19M
235.18%7.32M
-Change in inventory
115.49%922K
225.57%3.65M
39.72%-8.34M
152.94%6.67M
-501.76%-6.14M
-315.64%-5.95M
-339.90%-2.91M
-816.70%-13.83M
-745.74%-12.59M
-178.24%-1.02M
-Change in prepaid assets
-242.84%-2.77M
187.27%1.7M
-86.10%-5.16M
-171.46%-4.32M
88.25%-825K
81.84%1.94M
32.13%-1.95M
-124.33%-2.77M
-57.27%6.05M
43.06%-7.02M
-Change in payables and accrued expense
-523.64%-11.81M
-136.08%-10.52M
159.57%46.55M
117.27%16.48M
-149.71%-1.87M
3.64%2.79M
649.72%29.15M
594.95%17.93M
203.73%7.59M
-6.43%3.77M
-Change in other working capital
-171.59%-383K
-8.77%-372K
-1,309.84%-18.62M
-3,341.16%-14.21M
-1,366.56%-4.61M
293.84%535K
-7.55%-342K
43.18%-1.32M
13.96%-413K
40.08%-314K
Cash from discontinued investing activities
Operating cash flow
-100.29%-126K
-101.75%-33.51M
79.67%50.7M
364.76%37.56M
-1,340.58%-13.24M
400.31%42.99M
-258.53%-16.61M
-42.99%28.22M
-59.10%8.08M
-81.04%1.07M
Investing cash flow
Cash flow from continuing investing activities
99.99%-6K
-7,375.00%-12.56M
-1,531.22%-86.83M
81.63%-9K
-224,640.00%-11.24M
-65,679.13%-75.42M
96.88%-168K
70.83%-5.32M
71.18%-49K
97.51%-5K
Net PPE purchase and sale
---6K
65.48%-58K
44.89%-178K
79.59%-10K
--0
--0
56.25%-168K
56.76%-323K
71.18%-49K
97.51%-5K
Net business purchase and sale
----
----
---74.15M
--1K
--1.26M
----
----
--0
--0
--0
Net investment purchase and sale
--0
---12.5M
---12.5M
--0
---12.5M
--0
--0
--0
--0
----
Net other investing changes
----
----
----
----
----
----
----
---5M
--0
--0
Cash from discontinued investing activities
Investing cash flow
99.99%-6K
-7,375.00%-12.56M
-1,531.22%-86.83M
81.63%-9K
-224,640.00%-11.24M
-65,679.13%-75.42M
96.88%-168K
70.83%-5.32M
71.18%-49K
97.51%-5K
Financing cash flow
Cash flow from continuing financing activities
-1,096.08%-6.41M
211.34%12.65M
78.13%-6.21M
123.62%2.39M
132.84%3.3M
89.73%-536K
-276.09%-11.36M
25.03%-28.39M
-65.37%-10.11M
58.10%-10.04M
Net issuance payments of debt
-212.50%-6.25M
787.50%13.75M
259.55%12.76M
288.20%3.76M
750.00%13M
0.00%-2M
0.00%-2M
-60.00%-8M
0.00%-2M
-100.00%-2M
Net common stock issuance
--0
--0
15.13%-18M
--0
-20.31%-9.95M
--0
-462.36%-8.05M
39.39%-21.21M
-23.50%-8.65M
64.04%-8.27M
Proceeds from stock option exercised by employees
----
----
-27.15%1.75M
--0
6.01%247K
----
----
-34.37%2.4M
-82.03%557K
454.76%233K
Net other financing activities
-347.22%-161K
15.40%-1.1M
-72.23%-2.72M
-5,188.46%-1.38M
--0
---36K
15.86%-1.31M
-3.41%-1.58M
87.91%-26K
--0
Cash from discontinued financing activities
Financing cash flow
-1,096.08%-6.41M
211.34%12.65M
78.13%-6.21M
123.62%2.39M
132.84%3.3M
89.73%-536K
-276.09%-11.36M
25.03%-28.39M
-65.37%-10.11M
58.10%-10.04M
Net cash flow
Beginning cash position
-68.50%21.9M
-43.35%55.32M
-5.33%97.66M
-84.58%15.38M
-66.37%36.56M
-33.93%69.52M
-5.33%97.66M
-6.03%103.16M
11.22%99.74M
0.47%108.72M
Current changes in cash
80.15%-6.54M
-18.79%-33.42M
-670.34%-42.34M
2,018.20%39.94M
-135.94%-21.18M
-1,044.95%-32.96M
-1,456.65%-28.14M
16.98%-5.5M
-115.45%-2.08M
51.56%-8.98M
End cash Position
-58.01%15.35M
-68.50%21.9M
-43.35%55.32M
-43.35%55.32M
-84.58%15.38M
-66.37%36.56M
-33.93%69.52M
-5.33%97.66M
-5.33%97.66M
11.22%99.74M
Free cash flow
-100.31%-132K
-100.07%-33.57M
81.11%50.52M
367.47%37.55M
-1,346.42%-13.24M
393.71%42.99M
-266.23%-16.78M
-42.78%27.9M
-59.00%8.03M
-80.43%1.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -100.29%-126K-101.75%-33.51M79.67%50.7M364.76%37.56M-1,340.58%-13.24M400.31%42.99M-258.53%-16.61M-42.99%28.22M-59.10%8.08M-81.04%1.07M
Net income from continuing operations 154.65%5.16M-86.95%5.75M513.14%35.64M231.78%8.17M-26.84%-7.13M-361.63%-9.45M10,565.08%44.06M-171.96%-8.63M-176.90%-6.2M-179.64%-5.62M
Operating gains losses -106.54%-210K-83.04%326K79.85%9.86M-264.32%-6.06M352.68%10.79M-35.97%3.21M134.32%1.92M3.47%5.48M174.52%3.69M-60.59%2.38M
Depreciation and amortization 241.49%5.58M512.33%5.56M219.79%12.02M427.65%5.63M326.58%3.85M82.77%1.63M1.34%908K6.27%3.76M20.84%1.07M4.76%903K
Deferred tax 11.38%-1.78M10.24%-2.18M-130.07%-8.32M-230.05%-3.58M91.84%-298K-1,027.65%-2.01M-369.62%-2.43M-139.44%-3.62M-778.13%-1.09M-383.71%-3.65M
Other non cash items 190.27%1.16M11.78%446K-31.91%1.45M-83.94%178K103.02%471K26.10%401K-15.11%399K-53.83%2.13M-66.71%1.11M-63.00%232K
Change In working capital -131.83%-14.23M26.93%-48.05M-272.00%-16.4M504.24%29.11M-993.35%-24.46M878.80%44.71M-951.50%-65.76M1,068.75%9.54M-19.18%4.82M121.16%2.74M
-Change in receivables -100.41%-186K52.61%-42.52M-423.56%-30.83M485.12%24.49M-250.37%-11.01M682.70%45.4M-1,644.06%-89.71M406.10%9.53M286.88%4.19M235.18%7.32M
-Change in inventory 115.49%922K225.57%3.65M39.72%-8.34M152.94%6.67M-501.76%-6.14M-315.64%-5.95M-339.90%-2.91M-816.70%-13.83M-745.74%-12.59M-178.24%-1.02M
-Change in prepaid assets -242.84%-2.77M187.27%1.7M-86.10%-5.16M-171.46%-4.32M88.25%-825K81.84%1.94M32.13%-1.95M-124.33%-2.77M-57.27%6.05M43.06%-7.02M
-Change in payables and accrued expense -523.64%-11.81M-136.08%-10.52M159.57%46.55M117.27%16.48M-149.71%-1.87M3.64%2.79M649.72%29.15M594.95%17.93M203.73%7.59M-6.43%3.77M
-Change in other working capital -171.59%-383K-8.77%-372K-1,309.84%-18.62M-3,341.16%-14.21M-1,366.56%-4.61M293.84%535K-7.55%-342K43.18%-1.32M13.96%-413K40.08%-314K
Cash from discontinued investing activities
Operating cash flow -100.29%-126K-101.75%-33.51M79.67%50.7M364.76%37.56M-1,340.58%-13.24M400.31%42.99M-258.53%-16.61M-42.99%28.22M-59.10%8.08M-81.04%1.07M
Investing cash flow
Cash flow from continuing investing activities 99.99%-6K-7,375.00%-12.56M-1,531.22%-86.83M81.63%-9K-224,640.00%-11.24M-65,679.13%-75.42M96.88%-168K70.83%-5.32M71.18%-49K97.51%-5K
Net PPE purchase and sale ---6K65.48%-58K44.89%-178K79.59%-10K--0--056.25%-168K56.76%-323K71.18%-49K97.51%-5K
Net business purchase and sale -----------74.15M--1K--1.26M----------0--0--0
Net investment purchase and sale --0---12.5M---12.5M--0---12.5M--0--0--0--0----
Net other investing changes -------------------------------5M--0--0
Cash from discontinued investing activities
Investing cash flow 99.99%-6K-7,375.00%-12.56M-1,531.22%-86.83M81.63%-9K-224,640.00%-11.24M-65,679.13%-75.42M96.88%-168K70.83%-5.32M71.18%-49K97.51%-5K
Financing cash flow
Cash flow from continuing financing activities -1,096.08%-6.41M211.34%12.65M78.13%-6.21M123.62%2.39M132.84%3.3M89.73%-536K-276.09%-11.36M25.03%-28.39M-65.37%-10.11M58.10%-10.04M
Net issuance payments of debt -212.50%-6.25M787.50%13.75M259.55%12.76M288.20%3.76M750.00%13M0.00%-2M0.00%-2M-60.00%-8M0.00%-2M-100.00%-2M
Net common stock issuance --0--015.13%-18M--0-20.31%-9.95M--0-462.36%-8.05M39.39%-21.21M-23.50%-8.65M64.04%-8.27M
Proceeds from stock option exercised by employees ---------27.15%1.75M--06.01%247K---------34.37%2.4M-82.03%557K454.76%233K
Net other financing activities -347.22%-161K15.40%-1.1M-72.23%-2.72M-5,188.46%-1.38M--0---36K15.86%-1.31M-3.41%-1.58M87.91%-26K--0
Cash from discontinued financing activities
Financing cash flow -1,096.08%-6.41M211.34%12.65M78.13%-6.21M123.62%2.39M132.84%3.3M89.73%-536K-276.09%-11.36M25.03%-28.39M-65.37%-10.11M58.10%-10.04M
Net cash flow
Beginning cash position -68.50%21.9M-43.35%55.32M-5.33%97.66M-84.58%15.38M-66.37%36.56M-33.93%69.52M-5.33%97.66M-6.03%103.16M11.22%99.74M0.47%108.72M
Current changes in cash 80.15%-6.54M-18.79%-33.42M-670.34%-42.34M2,018.20%39.94M-135.94%-21.18M-1,044.95%-32.96M-1,456.65%-28.14M16.98%-5.5M-115.45%-2.08M51.56%-8.98M
End cash Position -58.01%15.35M-68.50%21.9M-43.35%55.32M-43.35%55.32M-84.58%15.38M-66.37%36.56M-33.93%69.52M-5.33%97.66M-5.33%97.66M11.22%99.74M
Free cash flow -100.31%-132K-100.07%-33.57M81.11%50.52M367.47%37.55M-1,346.42%-13.24M393.71%42.99M-266.23%-16.78M-42.78%27.9M-59.00%8.03M-80.43%1.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg